CMS Ventures, founded in 2020 and based in Cambridge, United Kingdom, is the corporate venture capital arm of China Medical System. The firm focuses on investing in biotechnology and life sciences startups across the United Kingdom, specializing in therapeutics, diagnostics, devices, and digital health. In addition to financing, CMS Ventures provides evaluation, coaching, mentoring, and advisory services to its portfolio companies.
Is CMS Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with CMS Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Seed, Series A
First ticket size
£62,000 - £1,000,000
When engaging CMS Ventures, founders should highlight how their technology or solution addresses significant unmet needs in healthcare, particularly with a clear path to clinical validation and commercialization. Demonstrating strong scientific rigor, a robust IP position, and a credible plan for regulatory and market access will resonate. Articulate how your startup can leverage CMS Ventures’ sector expertise and network to accelerate growth, especially if your innovation has potential for cross-border impact or strategic relevance to established healthcare players.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.